NEW!

Fractures resulting from osteoporosis become increasingly common in postmenopausal women and men aged 65 years and older. Globally, 1 in 3 women and 1 in 5 men over the age of 50 will experience an osteoporotic fracture. Notably, sufferers of these serious yet largely preventable injuries often experience severe pain, long-term disability and premature death. This video module reviews the role of denosumab as an effective long-term strategy for the management of osteoporosis.

Presenter:

Dr Michael R. McClung, MD, FACP

Professorial Fellow at Mary MacKillop Institute for Health,

Australian Catholic University, Melbourne, Australia;

Director of Oregon Osteoporosis Centre

• Lecture
• Q&A session

Who should participate:
• Doctors

NOTE :

Terms & Conditions: 

■ Participants must obtain a minimum score of 8/10 (80%) to be awarded 1 point. 
■ MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points

Please watch the video before attempting the assessment questions.

To play this video, you are required to have a media player such as Windows Media Player (PC), QuickTime (MAC) or another third party media player.